RSS
AYOXXA Biosystems
AYOXXA and Grünenthal validate protein multiplexing technology in inflammation study
AYOXXA Biosystems and Grünenthal have been using AYOXXA's protein multiplexing technology platform to analyse an inflammation marker at very low concentrations released from human cells following treatment in cell culture experiments. more